What documentation is required when a pharmacist notices a discrepancy in controlled substances?

When a pharmacist identifies a discrepancy in controlled substances, it is essential to ensure compliance with laws and regulations governing the handling of these substances. Immediate reporting to the Board of Pharmacy is required as they are the regulatory authority responsible for overseeing pharmacy practice, including the management and accountability of controlled substances.

This reporting allows the Board to investigate potential issues such as theft, diversion, or inventory errors effectively and mandates that action can be taken to address any discrepancies that could pose a risk to public safety. Furthermore, documentation and reporting to the Board are part of a pharmacy’s professional obligation and responsibility to maintain integrity and compliance within the pharmacy's operations.

Other options, while they may seem relevant, do not cover the necessary legal obligation to report to the Board of Pharmacy. For instance, an internal memo could be a useful method of communication within the pharmacy, but it does not fulfill the regulatory requirement for reporting discrepancies. Notifying local law enforcement may be appropriate in cases where there is evidence of criminal activity, but it is not the initial step mandated by pharmacy law. Additionally, completing a compliance checklist might help in addressing operational issues, but it is not a substitute for the formal reporting required to the Board.